Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
29.84
+0.25 (0.84%)
Feb 27, 2026, 4:00 PM EST - Market closed
Assembly Biosciences Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Assembly Biosciences stock have an average target of 43.4, with a low estimate of 38 and a high estimate of 50. The average target predicts an increase of 45.44% from the current stock price of 29.84.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 22, 2025.
Analyst Ratings
The average analyst rating for Assembly Biosciences stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +67.56% | Dec 22, 2025 |
| Mizuho | Mizuho | Buy Maintains $29 → $40 | Buy | Maintains | $29 → $40 | +34.05% | Nov 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +67.56% | Oct 14, 2025 |
| JMP Securities | JMP Securities | Buy Initiates $38 | Buy | Initiates | $38 | +27.35% | Sep 24, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $31 → $39 | Strong Buy | Maintains | $31 → $39 | +30.70% | Sep 8, 2025 |
Financial Forecast
Revenue This Year
38.03M
from 28.52M
Increased by 33.33%
Revenue Next Year
22.28M
from 38.03M
Decreased by -41.42%
EPS This Year
-3.63
from -6.69
EPS Next Year
-3.55
from -3.63
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 42.4M | 43.2M | ||||
| Avg | 38.0M | 22.3M | ||||
| Low | 29.4M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 48.8% | 13.7% | ||||
| Avg | 33.3% | -41.4% | ||||
| Low | 3.1% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -3.47 | -2.43 | ||||
| Avg | -3.63 | -3.55 | ||||
| Low | -3.79 | -5.53 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.